AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.
| Market Capitalization | $354.448 million |
| P/E Ratio | 36.11 |
| P/E Growth Ratio | |
| Book Value | 0.699 |
| Dividend Per Share | 0.011 |
| Earnings Per Share | 0.09 |
| EBITDA | 19,879 |
| Profit Margin | 0.068 |
| Operating Margin TTM | 0.1256 |
| Return on Assets TTM | 0.0893 |
| Return on Equity TTM | 0.1572 |
| Revenue TTM | 156,640.992 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2014-03-31 | 48,939 | 28,609 | 20,330 | 45,729 |
| 2015-03-31 | 56,241 | 35,083 | 21,158 | 62,206 |
| 2016-03-31 | 64,014 | 40,435 | 23,579 | 37,153 |
| 2017-03-31 | 69,047 | 43,207 | 25,840 | 43,042 |
| 2018-03-31 | 79,882 | 45,880 | 34,002 | 45,071 |
| 2019-03-31 | 85,127 | 44,397 | 40,730 | 36,330 |
| 2020-03-31 | 105,241 | 57,332 | 47,909 | 38,079 |
| 2021-03-31 | 112,861 | 64,364 | 48,497 | 39,763 |
| 2022-03-31 | 129,834 | 68,539 | 61,295 | 41,611 |
| 2023-03-31 | 155,820 | 83,658 | 72,162 | 55,038 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2014-03-31 | 1,242 | 25,467 | 22,419 | 13,137 | 13,137 | 33 |
| 2015-03-31 | 4,700 | 33,213 | 31,192 | 20,739 | 20,739 | 41 |
| 2016-03-31 | 28,055 | 65,304 | 37,074 | 23,161 | 23,161 | 53,902 |
| 2017-03-31 | 15,980 | 58,231 | 38,761 | 23,426 | 23,426 | 53,820 |
| 2018-03-31 | 6,770 | 56,603 | 49,261 | 30,654 | 30,654 | 54,619 |
| 2019-03-31 | 6,916 | 63,595 | 58,504 | 41,750 | 63,743 | |
| 2020-03-31 | 6,119 | 87,052 | 69,797 | 2,506 | 41,200 | 63,746 |
| 2021-03-31 | 3,209 | 105,132 | 68,544 | 5,775 | 33,200 | 77,197 |
| 2022-03-31 | 7,940 | 121,760 | 65,016 | 4,542 | 33,200 | 77,606 |
| 2023-03-31 | 4,749 | 148,063 | 74,795 | 3,029 | 32,200 | 78,240 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2014-03-31 | -1,113 | 66 | 165 | 763 | ||
| 2015-03-31 | -12,873 | -13,105 | 3,452 | 4,700 | 763 | |
| 2016-03-31 | -13,267 | -14,429 | 23,355 | 4,700 | 28,055 | 1,652 |
| 2017-03-31 | -18,388 | -19,062 | -12,075 | 28,055 | 15,980 | 412 |
| 2018-03-31 | -12,724 | -9,167 | -9,135 | 15,905 | 6,770 | 412 |
| 2019-03-31 | -2,427 | 1,067 | 146 | 6,770 | 6,916 | 134 |
| 2020-03-31 | 12,692 | 14,878 | -797 | 6,916 | 6,119 | -566 |
| 2021-03-31 | 7,782 | 750 | -2,910 | 6,119 | 3,209 | -188 |
| 2022-03-31 | 19,848 | 1,044 | 4,731 | 3,209 | 7,940 | |
| 2023-03-31 | 10,654 | 10,654 | -4,649 | 7,940 | 3,291 |